|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Mumps Virus IgG ELISA | Amyloid Beta Oligomers (82E1-specific) ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Leptin (Highly Sensitive) ELISA Assay | Parvovirus B19 IgG ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79882 | 27725 | 27600 | 27775 | IB79806 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Mumps Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against Mumps Virus in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of human Aß molecules which bind to nti-human Aß (N) (82E1) mouse MoAb with two or more epitopes (oligomers, polymers with a protein etc.) in serum, EDTA-plasma and brain tissue extract. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Solid phase sandwich ELISA for the determination of Human Leptin in serum, EDTA-plasma and supernatant of cell culture media. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of IgG-class antibodies to Parvovirus B19 in serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Tocilizumab (Actemra®) (mAb-based) | a-Synuclein | Metanephrine / Normetanephrine | Chromogranin A | Endothelin-1 |
| Sample Type | Serum and plasma. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Urine | Serum, Blood Plasma | Serum, EDTA-plasma, tissue extracted, cell culture supernatant |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 18.98 to 1215 pmol/L | 1.56 to 100.0 ng/mL | 15.63 to 1000 pg/mL | Cut-off control used to interpet results of unknowns. |
| Sensitivity | 2 ng/mL | 0.03 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 19 ng/mL | 0.39 pg/mL |
| Assay Time | 1 hr, 45 mins (incubation) | 2 hrs 30 mins (incubation) | 2 hours (incubation) | 2 hrs (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |